Reported Earnings • Jul 23
First quarter 2027 earnings released: EPS: ₹2.30 (vs ₹0.34 loss in 1Q 2026) First quarter 2027 results: EPS: ₹2.30 (up from ₹0.34 loss in 1Q 2026). Revenue: ₹324.9m (up 25% from 1Q 2026). Net income: ₹9.43m (up ₹10.8m from 1Q 2026). Profit margin: 2.9% (up from net loss in 1Q 2026). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Ankündigung • Jul 14
Amco India Limited to Report Q1, 2027 Results on Jul 22, 2026 Amco India Limited announced that they will report Q1, 2027 results on Jul 22, 2026 Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹0.81 (vs ₹4.56 in FY 2025) Full year 2026 results: EPS: ₹0.81 (down from ₹4.56 in FY 2025). Revenue: ₹1.19b (up 13% from FY 2025). Net income: ₹3.31m (down 82% from FY 2025). Profit margin: 0.3% (down from 1.8% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Ankündigung • May 21
Amco India Limited to Report Q4, 2026 Results on May 30, 2026 Amco India Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026 Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹76.00, the stock trades at a trailing P/E ratio of 50.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years. New Risk • Mar 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹286.2m market cap, or US$3.06m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin). New Risk • Feb 12
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹316.7m market cap, or US$3.49m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin). Reported Earnings • Feb 12
Third quarter 2026 earnings released: EPS: ₹0.37 (vs ₹1.60 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.37 (down from ₹1.60 in 3Q 2025). Revenue: ₹285.3m (flat on 3Q 2025). Net income: ₹1.51m (down 77% from 3Q 2025). Profit margin: 0.5% (down from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Ankündigung • Feb 02
Amco India Limited to Report Q3, 2026 Results on Feb 10, 2026 Amco India Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 10, 2026 Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹82.00, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years. Reported Earnings • Nov 05
Second quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.98 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.64 (down from ₹0.98 in 2Q 2025). Revenue: ₹343.6m (up 19% from 2Q 2025). Net income: ₹2.64m (down 34% from 2Q 2025). Profit margin: 0.8% (down from 1.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year. Ankündigung • Oct 27
Amco India Limited to Report Q2, 2026 Results on Nov 04, 2025 Amco India Limited announced that they will report Q2, 2026 results on Nov 04, 2025 Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹93.53, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years. Ankündigung • Sep 03
Amco India Limited, Annual General Meeting, Sep 30, 2025 Amco India Limited, Annual General Meeting, Sep 30, 2025, at 13:00 Indian Standard Time. Reported Earnings • Aug 15
First quarter 2026 earnings released: ₹0.34 loss per share (vs ₹1.13 profit in 1Q 2025) First quarter 2026 results: ₹0.34 loss per share (down from ₹1.13 profit in 1Q 2025). Revenue: ₹263.5m (up 12% from 1Q 2025). Net loss: ₹1.39m (down 130% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Ankündigung • Aug 09
Amco India Limited to Report Q1, 2026 Results on Aug 14, 2025 Amco India Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹95.57, the stock trades at a trailing P/E ratio of 21x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 5.1% over the past three years. New Risk • Jun 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Earnings have declined by 4.6% per year over the past 5 years. Market cap is less than US$10m (₹324.2m market cap, or US$3.74m). Reported Earnings • Jun 02
Full year 2025 earnings released: EPS: ₹4.56 (vs ₹2.01 in FY 2024) Full year 2025 results: EPS: ₹4.56 (up from ₹2.01 in FY 2024). Revenue: ₹1.07b (up 3.5% from FY 2024). Net income: ₹18.7m (up 127% from FY 2024). Profit margin: 1.7% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Ankündigung • May 22
Amco India Limited to Report Q4, 2025 Results on May 30, 2025 Amco India Limited announced that they will report Q4, 2025 results on May 30, 2025 New Risk • Apr 17
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10.0% average weekly change). Earnings have declined by 6.3% per year over the past 5 years. Market cap is less than US$10m (₹339.1m market cap, or US$3.96m). Minor Risk Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹76.30, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 7.5% over the past three years. Reported Earnings • Feb 16
Third quarter 2025 earnings released: EPS: ₹1.60 (vs ₹0.009 in 3Q 2024) Third quarter 2025 results: EPS: ₹1.60 (up from ₹0.009 in 3Q 2024). Revenue: ₹289.3m (up 1.6% from 3Q 2024). Net income: ₹6.59m (up ₹6.55m from 3Q 2024). Profit margin: 2.3% (up from 0% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Ankündigung • Feb 07
Amco India Limited to Report Q3, 2025 Results on Feb 14, 2025 Amco India Limited announced that they will report Q3, 2025 results on Feb 14, 2025 Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹94.27, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 6.8% over the past three years. Reported Earnings • Nov 15
Second quarter 2025 earnings released: EPS: ₹0.93 (vs ₹1.28 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.93 (down from ₹1.28 in 2Q 2024). Revenue: ₹291.5m (up 14% from 2Q 2024). Net income: ₹4.03m (down 24% from 2Q 2024). Profit margin: 1.4% (down from 2.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Ankündigung • Nov 06
Amco India Limited to Report Q2, 2025 Results on Nov 13, 2024 Amco India Limited announced that they will report Q2, 2025 results on Nov 13, 2024 Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹97.80, the stock trades at a trailing P/E ratio of 32.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years. Ankündigung • Oct 20
Amco India Limited Announces Board Appointments Amco India Limited announced change in the designation of Mrs. Vidhu Gupta as Non-Executive Non Independent Director of the company, at the AGM held on September 20, 2024. The company also announced that the appointment of Ms. Prarthana Gupta as an Independent Director of the Company. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹90.51, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years. Valuation Update With 7 Day Price Move • Sep 06
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₹80.26, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 85% over the past three years. Ankündigung • Aug 30
Amco India Limited, Annual General Meeting, Sep 20, 2024 Amco India Limited, Annual General Meeting, Sep 20, 2024, at 13:00 Indian Standard Time. Reported Earnings • Aug 14
First quarter 2025 earnings released: EPS: ₹1.13 (vs ₹0.12 in 1Q 2024) First quarter 2025 results: EPS: ₹1.13 (up from ₹0.12 in 1Q 2024). Revenue: ₹238.1m (down 19% from 1Q 2024). Net income: ₹4.66m (up ₹4.16m from 1Q 2024). Profit margin: 2.0% (up from 0.2% in 1Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Ankündigung • Aug 08
Amco India Limited to Report Q1, 2025 Results on Aug 13, 2024 Amco India Limited announced that they will report Q1, 2025 results on Aug 13, 2024 Ankündigung • Jul 18
Amco India Limited Announces Resignation of Mr. Dharam Pal Agarwal as Independent Director Amco India Limited announced that the resignation of Mr. Dharam Pal Agarwal as Independent Director of the Company. Mr. Dharam Pal Agarwal has expressed his desire to resign from the post of Independent Director of the Company with effect from 18 July, 2024, due to his other professional commitments. Consequently, he shall also cease to be the Chairman/Member of the various Committees of the Company. Ankündigung • May 24
Amco India Limited to Report Q4, 2024 Results on May 30, 2024 Amco India Limited announced that they will report Q4, 2024 results on May 30, 2024 Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.10 loss in 3Q 2023) Third quarter 2024 results: EPS: ₹0.01 (up from ₹0.10 loss in 3Q 2023). Revenue: ₹287.7m (down 25% from 3Q 2023). Net income: ₹36.0k (up ₹448.0k from 3Q 2023). Profit margin: 0% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings. Ankündigung • Feb 02
Amco India Limited to Report Q3, 2024 Results on Feb 09, 2024 Amco India Limited announced that they will report Q3, 2024 results on Feb 09, 2024 New Risk • Dec 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹277.3m market cap, or US$3.33m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Ankündigung • Sep 01
Amco India Limited, Annual General Meeting, Sep 30, 2023 Amco India Limited, Annual General Meeting, Sep 30, 2023, at 13:00 Indian Standard Time. Reported Earnings • Aug 13
First quarter 2024 earnings released: EPS: ₹0.12 (vs ₹1.33 in 1Q 2023) First quarter 2024 results: EPS: ₹0.12 (down from ₹1.33 in 1Q 2023). Revenue: ₹298.0m (down 20% from 1Q 2023). Net income: ₹499.0k (down 91% from 1Q 2023). Profit margin: 0.2% (down from 1.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Aug 05
Amco India Limited to Report Q1, 2024 Results on Aug 12, 2023 Amco India Limited announced that they will report Q1, 2024 results on Aug 12, 2023 Reported Earnings • Jun 04
Full year 2023 earnings released: EPS: ₹1.39 (vs ₹9.85 in FY 2022) Full year 2023 results: EPS: ₹1.39 (down from ₹9.85 in FY 2022). Revenue: ₹1.56b (flat on FY 2022). Net income: ₹5.70m (down 86% from FY 2022). Profit margin: 0.4% (down from 2.6% in FY 2022). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • May 23
Amco India Limited to Report Q4, 2023 Results on May 30, 2023 Amco India Limited announced that they will report Q4, 2023 results on May 30, 2023 Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 269% over the past three years. Reported Earnings • Feb 01
Third quarter 2023 earnings released: ₹0.10 loss per share (vs ₹2.57 profit in 3Q 2022) Third quarter 2023 results: ₹0.10 loss per share (down from ₹2.57 profit in 3Q 2022). Revenue: ₹386.8m (up 2.8% from 3Q 2022). Net loss: ₹412.0k (down 104% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Jan 21
Amco India Limited to Report Q3, 2023 Results on Jan 31, 2023 Amco India Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 31, 2023 Ankündigung • Jan 18
Amco India Limited Announces Resignation of Naseem Ahmad as Independent Director, Effective January 22, 2022 Amco India Limited announced the resignation of Mr. Naseem Ahmad as Independent Director, effective January 22, 2022. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Additional Non-Executive Independent Director Naseem Ahmad was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Ankündigung • Nov 03
Amco India Limited to Report First Half, 2023 Results on Nov 10, 2022 Amco India Limited announced that they will report first half, 2023 results on Nov 10, 2022 Ankündigung • Sep 09
Amco India Limited, Annual General Meeting, Sep 30, 2022 Amco India Limited, Annual General Meeting, Sep 30, 2022, at 13:00 Indian Standard Time. Agenda: To receive, consider and adopt the financial statement containing the Balance Sheet as at 31st March 2022 and the Profit and Loss Account for the financial year ended on that date along with the Cash Flow statements,Note & Schedules appended thereto together with the Boards' Report and the Auditors' Report thereon; to consider and appoint a director in place of Mr. Rajeev Gupta, who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment; and to consider the appointment of M/s V.V. Kale & Co., Chartered Accountants as Statutory Auditor of the Company. Reported Earnings • Aug 10
First quarter 2023 earnings released: EPS: ₹1.33 (vs ₹1.67 in 1Q 2022) First quarter 2023 results: EPS: ₹1.33 (down from ₹1.67 in 1Q 2022). Revenue: ₹376.8m (down 5.3% from 1Q 2022). Net income: ₹5.46m (down 21% from 1Q 2022). Profit margin: 1.4% (down from 1.7% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Aug 02
Amco India Limited to Report Q1, 2023 Results on Aug 09, 2022 Amco India Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 09, 2022 Valuation Update With 7 Day Price Move • Jun 28
Investor sentiment improved over the past week After last week's 19% share price gain to ₹69.95, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 242% over the past three years. Reported Earnings • Jun 04
Full year 2022 earnings released: EPS: ₹9.85 (vs ₹3.58 in FY 2021) Full year 2022 results: EPS: ₹9.85 (up from ₹3.58 in FY 2021). Revenue: ₹1.58b (up 77% from FY 2021). Net income: ₹40.5m (up 175% from FY 2021). Profit margin: 2.6% (up from 1.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Ankündigung • May 22
Amco India Limited to Report Q4, 2022 Final Results on May 30, 2022 Amco India Limited announced that they will report Q4, 2022 final results on May 30, 2022 Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Non-Executive Director Ankit Aggarwal was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Ankündigung • Apr 21
Amco India Limited Appoints Naseem Ahmad as an Additional Non-Executive Independent Director Amco India Limited announced that the Board of Directors of the Company based on the recommendation of Nomination and Remuneration Committee have appointed Mr. Naseem Ahmad as an additional Non-Executive Independent Director of the Company effective April 20, 2022. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 220% over the past three years. Reported Earnings • Feb 16
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹2.57 (up from ₹1.04 in 3Q 2021). Revenue: ₹379.9m (up 49% from 3Q 2021). Net income: ₹10.5m (up 146% from 3Q 2021). Profit margin: 2.8% (up from 1.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 48% per year. Ankündigung • Feb 08
Amco India Limited to Report Q3, 2022 Results on Feb 14, 2022 Amco India Limited announced that they will report Q3, 2022 results on Feb 14, 2022 Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹76.75, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 194% over the past three years. Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment improved over the past week After last week's 16% share price gain to ₹75.15, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 164% over the past three years. Reported Earnings • Nov 03
Second quarter 2022 earnings released: EPS ₹3.23 (vs ₹0.94 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹429.5m (up 93% from 2Q 2021). Net income: ₹13.3m (up 245% from 2Q 2021). Profit margin: 3.1% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 29% per year. Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment improved over the past week After last week's 29% share price gain to ₹56.50, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years. Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹1.67 (vs ₹0.47 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹397.8m (up 226% from 1Q 2021). Net income: ₹6.87m (up 273% from 1Q 2021). Profit margin: 1.7% (up from 1.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year. Reported Earnings • Jul 03
Full year 2021 earnings released: EPS ₹3.58 (vs ₹2.14 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹896.6m (up 4.2% from FY 2020). Net income: ₹14.7m (up 67% from FY 2020). Profit margin: 1.6% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improved over the past week After last week's 19% share price gain to ₹49.50, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 79% over the past three years. Valuation Update With 7 Day Price Move • May 28
Investor sentiment improved over the past week After last week's 16% share price gain to ₹34.50, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years. Reported Earnings • Feb 13
Third quarter 2021 earnings released: EPS ₹1.04 (vs ₹1.01 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₹255.7m (up 11% from 3Q 2020). Net income: ₹4.29m (up 3.9% from 3Q 2020). Profit margin: 1.7% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment improved over the past week After last week's 15% share price gain to ₹26.75, the stock is trading at a trailing P/E ratio of 18.1x, up from the previous P/E ratio of 15.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 36%. Ankündigung • Feb 05
Amco India Limited to Report Q3, 2021 Results on Feb 12, 2021 Amco India Limited announced that they will report Q3, 2021 results on Feb 12, 2021 Ankündigung • Feb 03
Amco India Limited Appoints Priyanka Beniwal as Company Secretary & Compliance Officer Amco India Limited announced that Board of Directors have appointed Ms. Priyanka Beniwal as Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effect from 2 February 2021. Is New 90 Day High Low • Jan 31
New 90-day low: ₹23.25 The company is down 4.0% from its price of ₹24.20 on 02 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 13
Second quarter 2021 earnings released: EPS ₹0.94 The company reported a soft second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹222.8m (up 1.9% from 2Q 2020). Net income: ₹3.85m (down 18% from 2Q 2020). Profit margin: 1.7% (down from 2.1% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Nov 04
Market bids up stock over the past week After last week's 17% share price gain to ₹26.65, the stock is trading at a trailing P/E ratio of 15.7x, up from the previous P/E ratio of 13.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 24%. Ankündigung • Jul 26
Amco India Limited to Report Q4, 2020 Results on Jul 31, 2020 Amco India Limited announced that they will report Q4, 2020 results on Jul 31, 2020 
